Abnormalities in Chromosomes 5 and 7 in Myelodysplastic Syndrome and Acute Myeloid Leukemia

被引:0
作者
Kendrick, Tulene S. [1 ,2 ,3 ]
Buic, Daria [2 ]
Fuller, Kathy A. [2 ]
Erber, Wendy N. [2 ,3 ]
机构
[1] Royal Perth Hosp, Haematol Dept, Perth, Australia
[2] Univ Western Australia, Sch Biomed Sci, Crawley, Australia
[3] PathWest Lab Med WA, Perth, Australia
关键词
Key Words; Acute myeloid leukemia; Chromosome; 5; 7; Monosomy; Myelo-dysplastic syndrome; THERAPY-RELATED MYELODYSPLASIA; IN-SITU HYBRIDIZATION; COMPLEX KARYOTYPE; MONOSOMAL KARYOTYPE; PROGNOSTIC IMPACT; MICROSATELLITE INSTABILITY; TP53; MUTATIONS; SCORING SYSTEM; DNA-SEQUENCE; NEUTRAL LOSS;
D O I
10.3343/alm.2024.0477
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Chromosomes 5 and 7 are large chromosomes that contain close to 1,000 genes each. Deletions of the long arms or loss of the entire chromosome (monosomy) are common defects in myeloid disorders, particularly MDS and AML. Loss of material from either chromosome 5 or 7 results in haploinsufficiency of multiple genes, with some implicated in leukemogenesis. Abnormalities of one or both occur in up to 15% of MDS and AML cases and co-segregate in half of these. Generally, these chromosomal abnormalities are harbingers of adverse risk in both myeloid disorders. A notable exception is del(5q) in 5q- syndrome, a subtype of MDS. In this review, we describe the pathogenesis and genetic consequences of deletions in chromosomes 5 and 7. Furthermore, we provide an overview of current testing methodologies used in the assessment of these chromosomal defects in hematological malignancies and describe the disease associations and prognostic implications of aberrations in chromosomes 5 and 7 in both MDS and AML.
引用
收藏
页码:133 / 145
页数:13
相关论文
共 97 条
  • [1] BRAF-Mutated Acute Myeloid Leukemia (AML) Represents a Distinct, Prognostically Poor Subgroup Enriched in Myelodysplasia-Related (MR-)AML
    Abu-Shihab, Yazan
    Nicolet, Deedra
    Mrozek, Krzysztof
    Routbort, Mark
    Patel, Keyur P.
    Walker, Christopher J.
    Buss, Jill
    Stiff, Andrew
    Laganson, Andrea
    DiNardo, Courtney D.
    Daver, Naval
    Kadia, Tapan M.
    Borthakur, Gautam
    Ravandi, Farhad
    Carroll, Andrew J.
    Kolitz, Jonathan E.
    Powell, Bayard L.
    Blum, William
    Baer, Maria R.
    Marcucci, Guido
    Uy, Geoffrey L.
    Stock, Wendy
    Stone, Richard M.
    Medeiros, L. Jeffrey
    Bowman, Robert L.
    Byrd, John C.
    Blachly, James S.
    Miles, Linde A.
    Eisfeld, Ann-Kathrin
    Loghavi, Sanam
    [J]. BLOOD, 2023, 142
  • [2] Diagnosis and Treatment of Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC)
    Arber, Daniel A.
    Erba, Harry P.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 154 (06) : 731 - 741
  • [3] Hidden monosomy 7 in acute myeloid leukemia and myelodysplastic syndrome detected by interphase fluorescence in situ hybridization
    Arif, T
    Tanaka, K
    Damodaran, C
    Asou, H
    Kyo, T
    Dohy, H
    Kamada, N
    [J]. LEUKEMIA RESEARCH, 1996, 20 (09) : 709 - 716
  • [4] Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia
    Aypar, Umut
    Smoley, Stephanie A.
    Pitel, Beth A.
    Pearce, Kathryn E.
    Zenka, Roman M.
    Vasmatzis, George
    Johnson, Sarah H.
    Smadbeck, James B.
    Peterson, Jess F.
    Geiersbach, Katherine B.
    Van Dyke, Daniel L.
    Thorland, Erik C.
    Jenkins, Robert B.
    Ketterling, Rhett P.
    Greipp, Patricia T.
    Kearney, Hutton M.
    Hoppman, Nicole L.
    Baughn, Linda B.
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (01) : 87 - 96
  • [5] The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia
    Banescu, Claudia
    Tripon, Florin
    Muntean, Carmen
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [6] New insights into 5q-syndrome as a ribosomopathy
    Barlow, Jillian L.
    Drynan, Lesley F.
    Trim, Nicola L.
    Erber, Wendy N.
    Warren, Alan J.
    McKenzie, Andrew N. J.
    [J]. CELL CYCLE, 2010, 9 (21) : 4286 - 4293
  • [7] The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin
    Baron, V
    Adamson, ED
    Calogero, A
    Ragona, G
    Mercola, D
    [J]. CANCER GENE THERAPY, 2006, 13 (02) : 115 - 124
  • [8] Does monosomy 5 really exist in myelodysplastic syndromes and acute myeloid leukemia?
    Belen Galvan, Ana
    Mallo, Mar
    Arenillas, Leonor
    Salido, Marta
    Espinet, Blanca
    Pedro, Carmen
    Florensa, Lourdes
    Serrano, Sergi
    Sole, Francesc
    [J]. LEUKEMIA RESEARCH, 2010, 34 (09) : 1242 - 1245
  • [9] Therapy-Related Myelodysplasia and Acute Myeloid Leukemia
    Bhatia, Smita
    [J]. SEMINARS IN ONCOLOGY, 2013, 40 (06) : 666 - 675
  • [10] Bishop R., 2010, Bioscience Horizons, V3, P85, DOI DOI 10.1093/BIOHORIZONS/HZQ009